Clinical Trial Update: Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune-tolerance with Alum-GAD and Vitamin D3 to children with multiple islet autoantibodies for Type 1 diabetes; study terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Alum-GAD
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Lund University | Conditions: Diabetes Mellitus, Type 1, Prediabetic State | Phase 2 | Status: TERMINATED | Results posted: 2020-10-27